Research News and Research

RSS

Senate continues to be embroiled in spending bill battles

March 18 is the deadline for work to be completed on spending for the current year, otherwise a government shutdown will take place. A Bloomberg poll found many Americans would oppose a shutdown, but also oppose deep cuts in programs such as Medicare and medical research. All the while, politics related to funding for the health law and Planned Parenthood are still heating up.

10 Mar 2011

Study finds synapses between retinal ganglion cells and starburst amacrine cells distributed asymmetrically

The sensory cells in the retina of the mammalian eye convert light stimuli into electrical signals and transmit them via downstream interneurons to the retinal ganglion cells which, in turn, forward them to the brain. The interneurons are connected to each other in such a way that the individual ganglion cells receive visual information from a circular area of the visual field known as the receptive field.

10 Mar 2011

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

10 Mar 2011

Feds gives Maine a break from insurance premium rules

Maine was granted leeway — the first such waiver given by the federal government — with the health law provision known as the medical-loss ratio because of concerns it would destabilize the state's insurance market.

10 Mar 2011

PPD introduces new online portal to enhance patient connectivity, improve retention in clinical trials

PPD, Inc. today announced it has launched an innovative online portal linking clinical trial participants with biopharmaceutical companies, physicians and health care resources to enhance patient connectivity and improve retention in clinical trials.

10 Mar 2011

Study reveals flexibility of neuronal processes underlying conscious perception

Our brains process many more stimuli than we become aware of. Often images enter our brain without being noticed: visual information is being processed, but does not reach consciousness, that is, we do not have an impression of it. Then, what is the difference between conscious and unconscious perception, and can both forms of perception be changed through practice?

10 Mar 2011

CUBN gene mutation linked with albuminuria in individuals with or without diabetes

A team of researchers from the United States and Europe has identified a single genetic mutation in the CUBN gene that is associated with albuminuria both with and without diabetes. Albuminuria is a condition caused by the leaking of the protein albumin into the urine, which is an indication of kidney disease.

9 Mar 2011

Medicaid and the health overhaul's goals

Media outlets report on how the health overhaul interacts with Medicaid and whether it will ultimately have a positive or negative impact on states.

9 Mar 2011

Viewpoints: Are waivers weakening health law?; Ill. 'Dangerous Docs'; Arizona transplants

It is irresponsible for the feds to dole out hundreds of millions without the assurance of insurance, payment and system reform, as well as universal coverage. That's the problem with Republican proposals to use a "block grant" approach in giving Medicaid dollars to the states to do with as they will. The president should use his precious time to encourage the law's implementation as soon as possible in areas of the country that are already on this road -- like our own Upper Midwest -- not to coddle his political enemies.

9 Mar 2011

KineMed extends collaboration with BMY to identify and characterize Alzheimer's biomarkers

KineMed, Inc. announced today the extension of its collaboration with Bristol-Myers Squibb in the area of Alzheimer's disease and other neurodegenerative conditions.

9 Mar 2011

NeuroDerm commences ND0611 Phase I/II trial to treat Parkinson's disease

NeuroDerm, Ltd. announced today the enrollment of the first group of patients in its Phase I/II clinical trial of ND0611, a new patch for the treatment of Parkinson's disease.

9 Mar 2011

Lowering cholesterol could help fight infections

British researchers have found that lowering cholesterol levels could help the body’s immune system fight infections. The team at the University of Edinburgh conducted the experiments on mice and found a direct link between the workings of the immune system and cholesterol levels.

9 Mar 2011

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced it has reached the target enrollment for the double-blind placebo-controlled phase III program of XIAFLEX for the treatment of Peyronie's disease.

9 Mar 2011

Camp STAR to offer evidence-based therapy for children with ADHD

Camp STAR, the Chicago area's only summer camp offering evidence-based therapy for children with Attention Deficit/Hyperactivity Disorder and other behavioral, emotional and social difficulties, begins its fourth season in June.

9 Mar 2011

Roundup: Legislatures pressured on health cuts, malpractice laws; Mass. Blue Cross board salaries; pension costs

This week, the Assembly and Senate will debate the final package of budget reductions. Among the $6 billion in health-related cuts is the elimination of the Maddy Fund, a $55 million attempt to reimburse emergency departments for indigent care.

9 Mar 2011

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

The U.S. Food and Drug Administration today approved Benlysta to treat patients with active, autoantibody-positive lupus who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.

9 Mar 2011

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

ERYtech Pharma announces the early completion of the enrollment and safety follow-up a Phase II clinical trial for GRASPA. This open-labeled trial introduced GRASPA in a first-line treatment for Acute Lymphoblastic Leukemia in patients older than 55 years.

9 Mar 2011

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.

9 Mar 2011

Study finds passive smoking increases risk of still birth by 23%

Pregnant non-smokers who breathe in the second-hand smoke of other people are at an increased risk of delivering stillborn babies or babies with defects, a study led by researchers at The University of Nottingham has found.

9 Mar 2011

Economic benefits of enabling people to age at home

There are a number of studies that look at the economics of technologies to enable people to age at home rather than in some other kind of accommodation. In 2010, CSES contributed an economic analysis for the ATSE report written by Greg Tegart drawing in part on these studies and using Australian data on demographic trends and healthcare costs.

9 Mar 2011

Research News and Research

Senate continues to be embroiled in spending bill battles

Study finds synapses between retinal ganglion cells and starburst amacrine cells distributed asymmetrically

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Feds gives Maine a break from insurance premium rules

PPD introduces new online portal to enhance patient connectivity, improve retention in clinical trials

Study reveals flexibility of neuronal processes underlying conscious perception

CUBN gene mutation linked with albuminuria in individuals with or without diabetes

Medicaid and the health overhaul's goals

Viewpoints: Are waivers weakening health law?; Ill. 'Dangerous Docs'; Arizona transplants

KineMed extends collaboration with BMY to identify and characterize Alzheimer's biomarkers

NeuroDerm commences ND0611 Phase I/II trial to treat Parkinson's disease

Lowering cholesterol could help fight infections

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Camp STAR to offer evidence-based therapy for children with ADHD

Roundup: Legislatures pressured on health cuts, malpractice laws; Mass. Blue Cross board salaries; pension costs

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Study finds passive smoking increases risk of still birth by 23%

Economic benefits of enabling people to age at home

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News